BioCentury
ARTICLE | Company News

Eisai sales and marketing update

May 5, 2014 7:00 AM UTC

Eisai launched Zonegran zonisamide in Russia to treat partial seizures, with or without secondary generalization, in adults with newly diagnosed epilepsy. ...